New strategies for combatting sepsis: the magic bullets missed the mark…but the search continues
- 1 February 1995
- journal article
- review article
- Published by Elsevier in Trends in Biotechnology
- Vol. 13 (2) , 56-63
- https://doi.org/10.1016/s0167-7799(00)88906-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Induction of Tumor Necrosis Factor- in Murine Candida albicans InfectionThe Journal of Infectious Diseases, 1993
- Molecular Mapping and Detoxification of the Lipid A Binding Site by Synthetic PeptidesScience, 1993
- American College of Chest Physicians/Society of Critical Care Medicine Consensus ConferenceCritical Care Medicine, 1992
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Prognostic Significance of Endotoxin Determination in Patients with Severe Intraabdominal InfectionThe Journal of Infectious Diseases, 1990
- Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies.The Journal of Experimental Medicine, 1990
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 1987